Completed PHASE2 INTERVENTIONAL 3-arm NCT00833690

Safety of Urate Elevation in Parkinson's Disease (SURE-PD)

A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease

Sponsor: Harvard School of Public Health (HSPH)

Conditions Parkinson Disease

Interventions Placebo inosine

Updated 7 times since 2017 Last updated: May 30, 2014 Started: Jun 30, 2009 Primary completion: Dec 31, 2012 Completion: Dec 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00833690, this PHASE2 trial focuses on Parkinson Disease and remains completed. Sponsored by Harvard School of Public Health (HSPH), it has been updated 7 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2022 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Jan 2022 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Jun 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Harvard School of Public Health (HSPH)
Massachusetts General Hospital
Michael J. Fox Foundation for Parkinson's Research
The Parkinson Study Group
University of Rochester

Data source: The Parkinson Study Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Boca Raton, United States , Boston, United States , Chicago, United States , Cincinnati, United States , Cleveland, United States , Durham, United States , East Lansing, United States , Golden Valley, United States , Los Angeles, United States , Manchester, United States and 5 more locations